The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain
Open accessAbstract
The glucagon-like peptide-1 receptor (GLP-1R) belongs to Family B1 of the seven-transmembrane G protein-coupled receptors, and its natural agonist ligand is the peptide hormone glucagon-like peptide-1 (GLP-1). GLP-1 is involved in glucose homeostasis, and activation of GLP-1R in the plasma membrane of pancreatic beta-cells potentiates glucose-dependent insulin secretion. The N-terminal extracellular domain (nGLP-1R) is an important ligand binding domain that binds GLP-1 and the homologous peptide Exendin-4 with differential affinity. Exendin-4 has a C-terminal extension of nine amino acid residues known as the "Trp cage", which is absent in GLP-1. The Trp cage was believed to interact with nGLP-1R and thereby explain the superior affinity of Exendin-4. However, the molecular details that govern ligand binding and specificity of nGLP-1R remain undefined. Here we report the crystal structure of human nGLP-1R in complex with the antagonist Exendin-4(9-39) solved by the multiwavelength anomalous dispersion method to 2.2A resolution. The structure reveals that Exendin-4(9-39) is an amphipathic alpha-helix forming both hydrophobic and hydrophilic interactions with nGLP-1R. The Trp cage of Exendin-4 is not involved in binding to nGLP-1R. The hydrophobic binding site of nGLP-1R is defined by discontinuous segments including primarily a well defined alpha-helix in the N terminus of nGLP-1R and a loop between two antiparallel beta-strands. The structure provides for the first time detailed molecular insight into ligand binding of the human GLP-1 receptor, an established target for treatment of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Kabsch, W. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889893005588 · Cited by 3,578
Automated protein model building combined with iterative structure refinement.
Anastassis Perrakis, A., Morris, R. J., & Lamzin, V. S. (1999) · Nature Structural Biology · doi:10.1038/8263 · Cited by 2,431
Automated Structure Solution With autoSHARP
Vonrhein, C., Blanc, E., Roversi, P., & Bricogne, G. (2006) · Macromolecular Crystallography Protocols, Volume 2 · doi:10.1385/1-59745-266-1:215 · Cited by 963
Göke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., & Göke, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36565-2 · Cited by 837
Designing a 20-residue protein
Neidigh, J. W., Fesinmeyer, R. M., & Andersen, N. H. (2002) · Nature Structural Biology · doi:10.1038/nsb798 · Cited by 793
International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List
Foord, S. M., Bonner, T. I., Neubig, R. R., Rosser, E. M., Pin, J.-P., Davenport, A. P., Spedding, M., & Harmar, A. J. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.5 · Cited by 592
Thorens, B., Porret, A., Bühler, L., Deng, S.-P., Morel, P., & Widmann, C. (1993) · Diabetes · doi:10.2337/diab.42.11.1678 · Cited by 558
Structure-activity studies of glucagon-like peptide-1.
Adelhorst, K., Hedegaard, B. B., Knudsen, L. B., & Kirk, O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37366-0 · Cited by 282
Neidigh, J. W., Fesinmeyer, R. M., Prickett, K. S., & Andersen, N. H. (2001) · Biochemistry · doi:10.1021/bi010902s · Cited by 204
High Potency Antagonists of the Pancreatic Glucagon-like Peptide-1 Receptor
Montrose-Rafizadeh, C., Yang, H., Rodgers, B. D., Beday, A., Pritchette, L. A., & Eng, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21201 · Cited by 171
Holtmann, M. H., Hadac, E. M., & Miller, L. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14394 · Cited by 165
Sun, C. C., Song, D., Davis‐Taber, R., Barrett, L. W., Scott, V., Richardson, P. L., Pereda‐Lopez, A., Uchic, M. E., Solomon, L. R., Lake, M. R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611397104 · Cited by 138
Runge, S., Wulff, B. S., Madsen, K., Bräuner‐Osborne, H., & Knudsen, L. B. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705120 · Cited by 133
Self-citationGrace, C. R., Perrin, M. H., Gulyás, J., DiGruccio, M. R., Cantle, J. P., Rivier, J., Vale, W., & Riek, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700682104 · Cited by 132
Grauschopf, U., Lilie, H., Honold, K., Wozny, M., Reusch, D., Eßwein, A., Schäfer, W., Rücknagel, K. P., & Rudolph, R. (2000) · Biochemistry · doi:10.1021/bi0001426 · Cited by 110
Self-citationde Maturana, R. L., Willshaw, A., Kuntzsch, A., Rudolph, R., & Donnelly, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212147200 · Cited by 105
Self-citationAl‐Sabah, S., & Donnelly, D. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705453 · Cited by 101
Runge, S., Schimmer, S., Oschmann, J., Schiødt, C. B., Knudsen, S. M., Jeppesen, C. B., Madsen, K., Lau, J. F., Thøgersen, H., & Rudolph, R. (2007) · Biochemistry · doi:10.1021/bi062309m · Cited by 95
Self-citationBazarsuren, A., Grauschopf, U., Wozny, M., et al. (2002) · Biophysical Chemistry · doi:10.1016/s0301-4622(02)00023-6 · Cited by 84
Solano, R. M., Langer, I., Perret, J., Vertongen, P., Juarranz, M. G., Robberecht, P., & Waelbroeck, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007696200 · Cited by 80
Perrin, M. H., Fischer, W. H., Kunitake, K. S., Craig, A. G., Koerber, S. C., Cervini, L. A., Rivier, J., Groppe, J. C., Greenwald, J., Nielsen, S. M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101838200 · Cited by 80
Tibaduiza, E. C., Chen, C., & Beinborn, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106692200 · Cited by 78
Carruthers, C. J. L., Unson, C. G., Kim, H. N., & Sakmar, T. P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62047-8 · Cited by 78
Runge, S., Gram, C., Bräuner‐Osborne, H., Madsen, K., Knudsen, L. B., & Wulff, B. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301085200 · Cited by 69
Self-citationMedium-Dependence of the secondary structure of exendin-4 and glucagon-like-peptide-1
Andersen, N. H., Brodsky, Y., Neidigh, J. W., & Prickett, K. S. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00263-2 · Cited by 66
Wittelsberger, A., Corich, M., Thomas, B. E., Lee, B.-K., Barazza, A., Czodrowski, P., Mierke, D. F., Chorev, M., & Rosenblatt, M. (2006) · Biochemistry · doi:10.1021/bi051833a · Cited by 56
Dong, M., Pinon, D. I., Asmann, Y. W., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.021840 · Cited by 46
Wilmen, A., Eyll, B. V., Göke, B., & Göke, R. (1997) · Peptides · doi:10.1016/s0196-9781(96)00321-x · Cited by 45
Al‐Sabah, S., & Donnelly, D. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01043-3 · Cited by 41
Dong, M., Li, Z., Zang, M., Pinon, D. I., Lybrand, T. P., & Miller, L. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309166200 · Cited by 40
de Maturana, R. L., Treece-Birch, J., Abidi, F., Findlay, J. B. C., & Donnelly, D. (2004) · Protein and Peptide Letters · doi:10.2174/0929866043478491 · Cited by 40
Graziano, M. P., Hey, P. J., & Strader, C. D. (1996) · PubMed · Cited by 36
Lisenbee, C. S., Dong, M., & Miller, L. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414016200 · Cited by 33
Eyll, B. V., Göke, B., Wilmen, A., & Göke, R. (1996) · Peptides · doi:10.1016/0196-9781(96)00019-8 · Cited by 26
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
The Discovery and Development of Liraglutide and Semaglutide
Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970
Self-citationAromatic Amide Foldamers: Structures, Properties, and Functions
Zhang, D.-W., Zhao, X., Hou, J.-L., & Li, Z.-T. (2012) · Chemical Reviews · doi:10.1021/cr300116k · Cited by 690
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Day, J. W., Ottaway, N., Patterson, J. T., Gelfanov, V., Smiley, D., Gidda, J., Findeisen, H., Bruemmer, D., Drucker, D. J., Chaudhary, N., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.209 · Cited by 641
Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein
Zhang, Y., Sun, B., Feng, D., Hu, H., Chu, M., Qu, Q., Tarrasch, J. T., Li, S., Sun Kobilka, T., Kobilka, B. K., et al. (2017) · Nature · doi:10.1038/nature22394 · Cited by 576
Metadata
- Authors
- Runge, S., Thøgersen, H., Madsen, K., Lau, J., & Rudolph, R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 283
- Issue
- 17
- Pages
- 11340-11347
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2112927642
- Cited by
- 291
- References
- 36
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.